Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-05

Clinical Trial Update: Trimethoprim-Sulfamethoxazole (TMP/SMX) Prophylaxis After Acute Kidney Injury to Prevent Post-discharge Infections [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating whether prophylaxis with trimethoprim-sulfamethoxazole after acute kidney injury reduces infections after hospital dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trimethoprim-sulfamethoxazole (trimethoprim-sulfamethoxazole)

Snippet

Sponsor: Hospital Civil de Guadalajara | Conditions: Acute Kidney Injuries, Acute Kidney Disease | Phase 2 | Status: NOT_YET_RECRUITING